Evaluation of the possible role of coenzyme Q10 vitamin E in juvenile neuronal ceroid-lipofuscinosis (JNCL)

Molecular Aspects of Medicine

Volumn 18, Issue SUPPL., 1997, Pages

  Westermarck, T ^a   Aberg L ^a   Santavuori, P ^d   Antila, E ^b   Edlund, P ^c   Atroshi, F ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Pharmacia Biopharmaceuticals   (Sweden)

^d NONE

Author keywords

Batten disease; CoQ10; NCL; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; UBIDECARENONE;

ADOLESCENT; ADULT; ANTIOXIDANT ACTIVITY; BLOOD LEVEL; CHILD; CONFERENCE PAPER; CONTROLLED STUDY; DEGENERATIVE DISEASE; HUMAN; MAJOR CLINICAL STUDY; NEURONAL CEROID LIPOFUSCINOSIS; PRESCHOOL CHILD; RECESSIVE INHERITANCE; SCHOOL CHILD; VITAMIN BLOOD LEVEL;

ADOLESCENT; ADULT; ANTIOXIDANTS; CHILD; CHILD, PRESCHOOL; CHOLESTEROL; HUMANS; NEURONAL CEROID-LIPOFUSCINOSES; UBIQUINONE; VITAMIN E;

EID: 0030826261     PISSN: 00982997     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0098-2997(97)00025-3     Document Type: Conference Paper

References (9)

1. Autti, T., Raininko, R., Vanhanen, S.-L. and Santavuori, P. (1996). MRI of neuronal ceroid lipofuscinosis. 1: Cranial MRI findings in the brains of 30 patients with juvenile neuronal ceroid lipofuscinosis. Neuroradiology, 38, 476-482.
2. 10 in free radical production and as an antioxidant: a review. Chemica Scripta, 27, 145-153.
3. 10, alpha-tocopherol and cholesterol in biological samples by coupled-column liquid chromatography with colourmetric and ultraviolet detection. Journal of Chromatography, 425, 87-97.
4. Frei, B., Kim, M. and Ames, B. (1990). Ubiquinol-10 is an effective lipid soluble antioxidant at physiological concentrations. Proceedings of the National Academy of Sciences of the USA, 87, 4879-4883.
5. Gutteridge, J. M. C., Rowley, D. A., Halliwell, B. and Westermarck, T. (1982). Increased non-protein bound iron and decreased protection against superoxide radical damage in cerebrospinal fluids from patients with neuronal ceroid lipofuscinosis. Lancet, 2, 459-460.
6. Karlsson, J., Diamant, B., Theorell, H. and Folkers, K. (1993). Ubiquinone and alpha-tocopherol in plasma; means of translocation or depot. The Clinical Investigator, 71S, 84-91.
7. Santavuori, P., Heiskala, H., Westermarck, T., Sainio, K. and Moren, R. (1988). Experience over 17 years with antioxidant treatment in Spielmeyer-Sjögren disease. American Journal of Medical Genetics, Supplement, 5, 265-274.
8. Walkley, S. U., March, P. A., Schroeder, C. E., Wurzelmann, S. and Jolly, R. D. (1995). Pathogenesis of brain dysfunction in Batten disease. American Journal of Medical Genetics, 57, 196-203.
9. Westermarck, T. (1977). Selenium content of tissues in Finnish infants and adults with various diseases, and studies on the effects of selenium supplementation in neuronal ceroid lipofuscinosis patients. Acta Pharmacologica Toxicologica, 41, 121-128.